Shares of Elevance Health, Inc. (NYSE:ELV – Get Free Report) have received a consensus recommendation of “Moderate Buy” from the thirteen analysts that are covering the stock, MarketBeat Ratings reports. One research analyst has rated the stock with a hold recommendation and twelve have assigned a buy recommendation to the company. The average 12-month price […]